Emerging role of miR-21 in non-alcoholic fatty liver disease

Samira Benhamouche-Trouillet¹, Catherine Postic^{2

3

4}

Affiliations

¹ BordeAux Research in Translational Oncology, Univ. Bordeaux, INSERM, U1053, Bordeaux, France.
² Inserm, U1016, Institut Cochin, Paris, France.
³ CNRS UMR 8104, Paris, France.
⁴ Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Comment

Samira Benhamouche-Trouillet et al. Gut. 2016 Nov.

. 2016 Nov;65(11):1781-1783.

doi: 10.1136/gutjnl-2015-310044. Epub 2016 Jul 19.

Samira Benhamouche-Trouillet¹, Catherine Postic^{2

3

4}

¹ BordeAux Research in Translational Oncology, Univ. Bordeaux, INSERM, U1053, Bordeaux, France.
² Inserm, U1016, Institut Cochin, Paris, France.
³ CNRS UMR 8104, Paris, France.
⁴ Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

No abstract available

Keywords: HEPATOCYTE; LIVER METABOLISM; NONALCOHOLIC STEATOHEPATITIS.

Comment on

Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption.
Calo N, Ramadori P, Sobolewski C, Romero Y, Maeder C, Fournier M, Rantakari P, Zhang FP, Poutanen M, Dufour JF, Humar B, Nef S, Foti M. Calo N, et al. Gut. 2016 Nov;65(11):1871-1881. doi: 10.1136/gutjnl-2015-310822. Epub 2016 May 24. Gut. 2016. PMID: 27222533